Torii Peptide
Torii Peptide (APJ Endogenous Ligand Fragment)
A synthetic APJ receptor-activating peptide designed for cardiovascular protection and longevity. Activates the apelin/APJ pathway with enhanced stability.
Mechanism of Action
This synthetic peptide activates APJ receptors with improved pharmacokinetic properties compared to native apelin. It produces cardioprotection, vasodilation, and metabolic improvements.
Health Claims & Evidence
Cardioprotective effects via APJ activation
Vasodilatory and blood pressure reduction
Metabolic improvements
Short-Term Effects
Improved cardiac function, vasodilation.
Long-Term Effects
Research use primarily.
Side Effects
Limited human data.
Contraindications
Limited human safety data.
This profile is provided for educational research only. It is not a treatment recommendation or dosing guide. Human evidence, safety information and regulatory status vary by substance. Verify primary sources and consult a qualified healthcare professional for medical decisions.
Research Papers
APJ receptor agonists and cardiovascular protection
Murza et al. · Journal of Medicinal Chemistry · 2016
Educational research only. This profile is not a treatment recommendation or dosing guide. Human evidence, safety information and regulatory status vary by substance. Consult a qualified healthcare professional for medical decisions.
Related Peptides
Explore the research further
Our AI Research Advisor can help you explore the evidence on Torii Peptide and related peptides, and prepare an educational research summary.
Explore Research